
Cytokine-armored CAR-T cell therapy helps eliminate aggressive brain tumors in preclinical study
New approach recruits the body’s immune system to attack glioblastoma while reducing treatment-related toxicity

New approach recruits the body’s immune system to attack glioblastoma while reducing treatment-related toxicity